YSNASDAQHealthcare · Biotechnology

YS Biopharma Co., Ltd.

$1.02+9.68%(+$0.09)

TickerSpark Score

74/100

Solid

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YS research report →

52-Week Range47% of range

Low $0.35

Current $1.02

High $1.78

Companywww.yishengbio.com

YS Biopharma Co. , Ltd. , a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer.

CEO: Hui Shao
IPO: 2021
Employees: 773
HQ: Beijing, CN

Price Chart

-50.00% · this period

Valuation

Market Cap: $192.09M
P/E: -0.27
P/S: 0.02
P/B: 0.05
EV/EBITDA: -8.17
Div Yield: 0.00%

Profitability

Gross Margin: 82.47%
Op Margin: -14.03%
Net Margin: -16.26%
ROE: -18.43%
ROIC: -9.15%

Growth & Income

Revenue: $614.96M · 7.24%
Net Income: $-99,982,451 · 76.93%
EPS: $-0.94 · 76.79%
Op Income: $-86,291,884
FCF YoY: 59.10%

Performance & Tape

52W High: $1.78
52W Low: $0.35
50D MA: $0.87
200D MA: $0.66
Beta: 0.54
Avg Volume: 130.56K

Get TickerSpark's AI analysis on YS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime